Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Raghunath

Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks may help deliver steady gains across business cycles. Typically, healthcare companies are viewed as recession-resistant, and enjoy a stable stream of cash flows. Further, these companies invest heavily in research and development, enabling them to treat a wide range of diseases, making healthcare players a key part of the global economy. 

In the past two decades, healthcare giants such as Novo Nordisk (NVO) and Eli Lilly & Co. (LLY) have delivered substantial returns to shareholders. While Eli Lilly stock is up 1,751% over this time frame, Novo Nordisk stock has surged a staggering 7,565% since February 2004, after adjusting for dividends. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.